Global Behcet's Disease Therapeutics Market 2024-2028

PUBLISHED: December 13, 2023

PAGES: 149 Pages

DELIVERY TIME: 1-2 business days

ADD TO COMPARE

SELECT AN OPTION

The behcet's disease therapeutics market is forecasted to grow by USD 437.57 mn during 2023-2028, accelerating at a CAGR of 6.82% during the forecast period. The report on the behcet's disease therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the heavy use of off-label drugs, special drug designations, and increasing research funding for rare diseases.

Market Scope
Base Year	2023
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	5.7%
CAGR	6.82%
Incremental Value	$437.57mn

Technavio's behcet's disease therapeutics market is segmented as below:

By Route Of Administration

Oral
Injectable

By Product

Small molecules
Biologics

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increasing awareness about rare diseases as one of the prime reasons driving the behcet's disease therapeutics market growth during the next few years. Also, strategic alliances among vendors and the advent of novel therapeutics will lead to sizable demand in the market.

The report on the behcet's disease therapeutics market covers the following areas:

Behcet's disease therapeutics market sizing
Behcet's disease therapeutics market forecast
Behcet's disease therapeutics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading behcet's disease therapeutics market vendors that include AbbVie Inc., Amgen Inc., F. Hoffmann La Roche Ltd., Johnson and Johnson, Mitsubishi Chemical Group Corp., Novartis AG, Pfizer Inc., Takeda Pharmaceutical Co. Ltd., Viatris Inc., and Xoma Corp.. Also, the behcet's disease therapeutics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR73638

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global Behcets disease therapeutics market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global behcets disease therapeutics market 2018 - 2022 ($ million)
4.2 Route of Administration Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
4.3 Product Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Route of Administration

6.1 Market segments
Exhibit 30: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibit 31: Data Table on Route of Administration - Market share 2023-2028 (%)
6.2 Comparison by Route of Administration
Exhibit 32: Chart on Comparison by Route of Administration
Exhibit 33: Data Table on Comparison by Route of Administration
6.3 Oral - Market size and forecast 2023-2028
Exhibit 34: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibit 35: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibit 36: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Oral - Year-over-year growth 2023-2028 (%)
6.4 Injectable - Market size and forecast 2023-2028
Exhibit 38: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibit 39: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibit 40: Chart on Injectable - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Route of Administration
Exhibit 42: Market opportunity by Route of Administration ($ million)
Exhibit 43: Data Table on Market opportunity by Route of Administration ($ million)

7 Market Segmentation by Product

7.1 Market segments
Exhibit 44: Chart on Product - Market share 2023-2028 (%)
Exhibit 45: Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Exhibit 46: Chart on Comparison by Product
Exhibit 47: Data Table on Comparison by Product
7.3 Small molecules - Market size and forecast 2023-2028
Exhibit 48: Chart on Small molecules - Market size and forecast 2023-2028 ($ million)
Exhibit 49: Data Table on Small molecules - Market size and forecast 2023-2028 ($ million)
Exhibit 50: Chart on Small molecules - Year-over-year growth 2023-2028 (%)
Exhibit 51: Data Table on Small molecules - Year-over-year growth 2023-2028 (%)
7.4 Biologics - Market size and forecast 2023-2028
Exhibit 52: Chart on Biologics - Market size and forecast 2023-2028 ($ million)
Exhibit 53: Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
Exhibit 54: Chart on Biologics - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Product
Exhibit 56: Market opportunity by Product ($ million)
Exhibit 57: Data Table on Market opportunity by Product ($ million)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 61: Chart on Geographic comparison
Exhibit 62: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 63: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibit 65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 66: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibit 69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibit 73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 79: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibit 80: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibit 81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Japan - Market size and forecast 2023-2028
Exhibit 83: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 84: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibit 85: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 87: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 88: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibit 89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 Canada - Market size and forecast 2023-2028
Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.11 Germany - Market size and forecast 2023-2028
Exhibit 95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibit 97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 99: Market opportunity By Geographical Landscape ($ million)
Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 101: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 103: Overview on factors of disruption
11.4 Industry risks
Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 105: Vendors covered
12.2 Market positioning of vendors
Exhibit 106: Matrix on vendor position and classification
12.3 AbbVie Inc.
Exhibit 107: AbbVie Inc. - Overview
Exhibit 108: AbbVie Inc. - Product / Service
Exhibit 109: AbbVie Inc. - Key news
Exhibit 110: AbbVie Inc. - Key offerings
12.4 Amgen Inc.
Exhibit 111: Amgen Inc. - Overview
Exhibit 112: Amgen Inc. - Product / Service
Exhibit 113: Amgen Inc. - Key offerings
12.5 F. Hoffmann La Roche Ltd.
Exhibit 114: F. Hoffmann La Roche Ltd. - Overview
Exhibit 115: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 116: F. Hoffmann La Roche Ltd. - Key news
Exhibit 117: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 118: F. Hoffmann La Roche Ltd. - Segment focus
12.6 Johnson and Johnson
Exhibit 119: Johnson and Johnson - Overview
Exhibit 120: Johnson and Johnson - Business segments
Exhibit 121: Johnson and Johnson - Key news
Exhibit 122: Johnson and Johnson - Key offerings
Exhibit 123: Johnson and Johnson - Segment focus
12.7 Mitsubishi Chemical Group Corp.
Exhibit 124: Mitsubishi Chemical Group Corp. - Overview
Exhibit 125: Mitsubishi Chemical Group Corp. - Business segments
Exhibit 126: Mitsubishi Chemical Group Corp. - Key offerings
Exhibit 127: Mitsubishi Chemical Group Corp. - Segment focus
12.8 Novartis AG
Exhibit 128: Novartis AG - Overview
Exhibit 129: Novartis AG - Business segments
Exhibit 130: Novartis AG - Key offerings
Exhibit 131: Novartis AG - Segment focus
12.9 Pfizer Inc.
Exhibit 132: Pfizer Inc. - Overview
Exhibit 133: Pfizer Inc. - Product / Service
Exhibit 134: Pfizer Inc. - Key news
Exhibit 135: Pfizer Inc. - Key offerings
12.10 Takeda Pharmaceutical Co. Ltd.
Exhibit 136: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibit 137: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibit 138: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibit 139: Takeda Pharmaceutical Co. Ltd. - Key offerings
12.11 Viatris Inc.
Exhibit 140: Viatris Inc. - Overview
Exhibit 141: Viatris Inc. - Business segments
Exhibit 142: Viatris Inc. - Key news
Exhibit 143: Viatris Inc. - Key offerings
Exhibit 144: Viatris Inc. - Segment focus
12.12 Xoma Corp.
Exhibit 145: Xoma Corp. - Overview
Exhibit 146: Xoma Corp. - Product / Service
Exhibit 147: Xoma Corp. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 148: Inclusions checklist
Exhibit 149: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 150: Currency conversion rates for US$
13.4 Research methodology
Exhibit 151: Research methodology
Exhibit 152: Validation techniques employed for market sizing
Exhibit 153: Information sources
13.5 List of abbreviations
Exhibit 154: List of abbreviations

Product Code: IRTNTR73638

Exhibits:

Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits5: Executive Summary - Chart on Market Segmentation by Route of Administration
Exhibits6: Executive Summary - Chart on Market Segmentation by Product
Exhibits7: Executive Summary - Chart on Incremental Growth
Exhibits8: Executive Summary - Data Table on Incremental Growth
Exhibits9: Executive Summary - Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Historic Market Size - Data Table on global behcets disease therapeutics market 2018 - 2022 ($ million)
Exhibits19: Historic Market Size - Route of Administration Segment 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Route of Administration - Market share 2023-2028 (%)
Exhibits31: Data Table on Route of Administration - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Route of Administration
Exhibits33: Data Table on Comparison by Route of Administration
Exhibits34: Chart on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Oral - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Oral - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Oral - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Injectable - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Injectable - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Route of Administration ($ million)
Exhibits43: Data Table on Market opportunity by Route of Administration ($ million)
Exhibits44: Chart on Product - Market share 2023-2028 (%)
Exhibits45: Data Table on Product - Market share 2023-2028 (%)
Exhibits46: Chart on Comparison by Product
Exhibits47: Data Table on Comparison by Product
Exhibits48: Chart on Small molecules - Market size and forecast 2023-2028 ($ million)
Exhibits49: Data Table on Small molecules - Market size and forecast 2023-2028 ($ million)
Exhibits50: Chart on Small molecules - Year-over-year growth 2023-2028 (%)
Exhibits51: Data Table on Small molecules - Year-over-year growth 2023-2028 (%)
Exhibits52: Chart on Biologics - Market size and forecast 2023-2028 ($ million)
Exhibits53: Data Table on Biologics - Market size and forecast 2023-2028 ($ million)
Exhibits54: Chart on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits55: Data Table on Biologics - Year-over-year growth 2023-2028 (%)
Exhibits56: Market opportunity by Product ($ million)
Exhibits57: Data Table on Market opportunity by Product ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits64: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits65: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits66: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits67: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits68: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits69: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits70: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits71: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits72: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits73: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits74: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits75: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits76: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits77: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits78: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits79: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits80: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits81: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits82: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits83: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits84: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits85: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits86: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits87: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits88: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits89: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits90: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits91: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits92: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits93: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits94: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits95: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits96: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits97: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits98: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2023 and 2028
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: AbbVie Inc. - Overview
Exhibits108: AbbVie Inc. - Product / Service
Exhibits109: AbbVie Inc. - Key news
Exhibits110: AbbVie Inc. - Key offerings
Exhibits111: Amgen Inc. - Overview
Exhibits112: Amgen Inc. - Product / Service
Exhibits113: Amgen Inc. - Key offerings
Exhibits114: F. Hoffmann La Roche Ltd. - Overview
Exhibits115: F. Hoffmann La Roche Ltd. - Business segments
Exhibits116: F. Hoffmann La Roche Ltd. - Key news
Exhibits117: F. Hoffmann La Roche Ltd. - Key offerings
Exhibits118: F. Hoffmann La Roche Ltd. - Segment focus
Exhibits119: Johnson and Johnson - Overview
Exhibits120: Johnson and Johnson - Business segments
Exhibits121: Johnson and Johnson - Key news
Exhibits122: Johnson and Johnson - Key offerings
Exhibits123: Johnson and Johnson - Segment focus
Exhibits124: Mitsubishi Chemical Group Corp. - Overview
Exhibits125: Mitsubishi Chemical Group Corp. - Business segments
Exhibits126: Mitsubishi Chemical Group Corp. - Key offerings
Exhibits127: Mitsubishi Chemical Group Corp. - Segment focus
Exhibits128: Novartis AG - Overview
Exhibits129: Novartis AG - Business segments
Exhibits130: Novartis AG - Key offerings
Exhibits131: Novartis AG - Segment focus
Exhibits132: Pfizer Inc. - Overview
Exhibits133: Pfizer Inc. - Product / Service
Exhibits134: Pfizer Inc. - Key news
Exhibits135: Pfizer Inc. - Key offerings
Exhibits136: Takeda Pharmaceutical Co. Ltd. - Overview
Exhibits137: Takeda Pharmaceutical Co. Ltd. - Product / Service
Exhibits138: Takeda Pharmaceutical Co. Ltd. - Key news
Exhibits139: Takeda Pharmaceutical Co. Ltd. - Key offerings
Exhibits140: Viatris Inc. - Overview
Exhibits141: Viatris Inc. - Business segments
Exhibits142: Viatris Inc. - Key news
Exhibits143: Viatris Inc. - Key offerings
Exhibits144: Viatris Inc. - Segment focus
Exhibits145: Xoma Corp. - Overview
Exhibits146: Xoma Corp. - Product / Service
Exhibits147: Xoma Corp. - Key offerings
Exhibits148: Inclusions checklist
Exhibits149: Exclusions checklist
Exhibits150: Currency conversion rates for US$
Exhibits151: Research methodology
Exhibits152: Validation techniques employed for market sizing
Exhibits153: Information sources
Exhibits154: List of abbreviations